Doliver Advisors, LP Amgen Inc Transaction History

Doliver Advisors, LP

$346 Million
Q3 2024

A detailed history of Doliver Advisors, LP transactions in Amgen Inc stock. As of the latest transaction made, Doliver Advisors, LP holds 5,686 shares of AMGN stock, worth $1.59 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

5,686

Previous 6,117 7.05%

Holding current value

$1.59 Million

Previous $1.91 Million 4.13%

% of portfolio

0.53%

Previous 0.55%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$309.38 - $337.38 $133,342 - $145,410	-431 Reduced 7.05%	5,686 $1.83 Million
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $86,970 - $105,691	-331 Reduced 5.13%	6,117 $1.91 Million
Q1 2024 Apr 12, 2024	BUY	$268.87 - $324.56 $61,571 - $74,324	229 Added 3.68%	6,448 $1.83 Million
Q4 2023 Jan 03, 2024	SELL	$255.7 - $288.46 $4,858 - $5,480	-19 Reduced 0.3%	6,219 $1.79 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $1,311 - $1,628	-6 Reduced 0.1%	6,238 $1.68 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $76,922 - $90,959	359 Added 6.1%	6,244 $1.39 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $418,163 - $509,670	1,852 Added 45.92%	5,885 $1.42 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $55,654 - $70,715	-243 Reduced 5.68%	4,033 $1.06 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $14,140 - $15,948	63 Added 1.5%	4,276 $964,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $48,910 - $54,428	212 Added 5.3%	4,213 $1.03 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $62,930 - $69,617	-287 Reduced 6.69%	4,001 $968,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $33,809 - $38,692	170 Added 4.13%	4,288 $952,000
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $147,315 - $172,597	694 Added 20.27%	4,118 $876,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $190,134 - $210,939	814 Added 31.19%	3,424 $835,000
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $60,137 - $70,080	271 Added 11.59%	2,610 $649,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $190,414 - $226,749	880 Added 60.32%	2,339 $538,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $32,851 - $36,533	140 Added 10.61%	1,459 $371,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $75,563 - $92,726	382 Added 40.77%	1,319 $311,000
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $79,274 - $105,139	-435 Reduced 31.71%	937 $227,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $79,468 - $102,144	-420 Reduced 23.44%	1,372 $331,000
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $20,893 - $25,034	120 Added 7.18%	1,792 $367,000
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $278,722 - $326,725	1,672 New	1,672 $308,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $187,743 - $211,627	-1,038 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $3,568 - $4,165	20 Added 1.96%	1,038 $202,000
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 8.94%	1,018 $211,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $185,643 - $208,518	1,118 New	1,118 $207,000

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Doliver Advisors, LP with notifications on news.

Account

Doliver Advisors, LP Amgen Inc Transaction History